![](https://cdn.snapi.dev/images/v1/d/c/press11-2.jpg)
News for ProQR Therapeutics Stock (PRQR)
![](https://cdn.snapi.dev/images/v1/d/c/press11-2.jpg)
![](https://cdn.snapi.dev/images/v1/g/v/press18-2.jpg)
![](https://cdn.snapi.dev/images/v1/n/u/press2-2.jpg)
![](https://cdn.snapi.dev/images/v1/w/c/press18-2.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/s/s/biotech15.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/w/u/press4.jpg)
24/7 Wall Street •
![](https://cdn.snapi.dev/images/v1/4/6/46prqthess-1.jpg)
Market Watch •
![](https://cdn.snapi.dev/images/v1/4/2/42pqpaoj-1.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/f/w/press1.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/r/d/biotech22.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/8/l/biotech29.jpg)
![](https://cdn.snapi.dev/images/v1/h/a/press9.jpg)
![](https://cdn.snapi.dev/images/v1/3/u/press9.jpg)
ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/x/e/press11.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/a/p/press17.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/d/f/press20.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/g/k/biotech17.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/c/n/press8.jpg)
Seeking Alpha •
![](https://cdn.snapi.dev/images/v1/p/z/biotech1.jpg)
GlobeNewsWire •
![](https://cdn.snapi.dev/images/v1/q/a/press17.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/d/x/biotech27.jpg)
Seeking Alpha •
![](https://cdn.snapi.dev/images/v1/g/w/biotech40.jpg)